Non-alcoholic fatty liver disease (NAFLD) is projected to become the leading cause of
hepatocellular carcinoma (HCC) in many countries. Many risk factors for NAFLD are also …

Background and Aims Recent studies link NAFLD to an increased incidence of HCC and
extrahepatic cancers. However, earlier studies were small or lacked liver histology, which …

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) has been implicated as a
cause of hepatocellular carcinoma (HCC). We performed a systematic review of …

Recent data suggest that non-alcoholic fatty liver disease (NAFLD) has become a major
public health problem in Asia, with an updated population prevalence of 34%. In parallel …

Background and aims Hepatic steatosis of nonalcoholic etiology (nonalcoholic fatty liver
disease; NAFLD) is an emergent condition that may lead to hepatic cirrhosis and finally to …

Non-alcoholic fatty liver disease (NAFLD) has emerged as the most common liver disorder
worldwide mainly attributed to the epidemic spread of obesity and type 2 diabetes mellitus …

One quarter of the global population is estimated to have nonalcoholic fatty liver disease
(NAFLD). The incidence of nonalcoholic steatohepatitis (NASH) is projected to increase by …

Caloric excess and sedentary lifestyle have led to a global epidemic of obesity and
metabolic syndrome. The hepatic consequence of metabolic syndrome and obesity …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading
cause of cancer‐related mortality worldwide. Non‐alcoholic fatty liver disease (NAFLD) …

Background and Aims The long‐term risk of disease for patients with nonalcoholic fatty liver
disease (NAFLD) in the absence of elevated enzymes is unclear. We conducted a …